• GeneCentric Therapeutics Acquires Select ImmunoGenomics americanpharmaceuticalreview
    August 20, 2019
    GeneCentric Therapeutics has acquired Select ImmunoGenomics, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs.
PharmaSources Customer Service